Oculis Holding AG

US$7.49As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:OCSHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (4.64%)
Div yield —
ROE (47.49%)
Biotechnology
Beta (5Y) 0.29
PE TTM —
TSR TTM (61.15%)
Mkt cap US$462.4M
ROIC (32.49%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$9.57
27.72%
(28.39%)
Hold 8|1|12|5|1
4Q25
1Q26
2Q26
3Q26
Earnings per shareFr
0.13
0.13
0.13
0.14
(2.73%)
4.24%
2.67%
10.69%
RevenueFr M
19.78
20.48
20.49
20.72
(2.98%)
(1.22%)
0.46%
3.85%
Peers (US$462.4M)
Cap (US$)
PE
221.7M
—
462.3M
43.75x
Capital
TTM
5Y
10Y
Leveragex
5.344
3.395
2.492
EBIT/Intx
0.510
0.052
0.057
Own earn%
(21.83)
(78.09)
(77.35)
Sh yield%
23.38
51.79
51.30
Owners
Insiders/Inst%
4.11
86.91
Short interest%
4.88
SBC / revenue%
4.14
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
19–26
$1 testx
0.4
Incr. ROIC%
0